Abstract
599 Background: The assessment of the needs of the adjuvant chemotherapy has been the important problem in luminal type breast cancers. Multigene prognosis assays such as Oncotype Dx and Mammaprint, turned out to be efficient techniques. However, these assays are expensive and have not been prospectively validated. The transcription factors GATA-binding protein 3 (GATA-3) and Forkhead-box protein A1 (FOXA1) function with estrogen receptor α (ERα) in mammary morphogenesis. These transcription factors form an autoregulatory hormonal network that influences estrogen responsiveness and sensitivity to hormonal therapy. Methods: We analyzed GATA-3 and FOXA1 expression in 307 primary breast cancers by immunohistochemistry, to evaluate the association with breast cancer molecular markers, clinicopathological features and patients’ recurrence-free survival. We classified the cases into luminal A and B using hormonal receptors, HER2 and Ki67 index (cut-off value: 14%). Results: 1.GATA-3 expression was positively co...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
